ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PNTG vs OMDA // RETURN ON INVESTED CAPITAL (ROIC)

The Pennant Group Inc. (NASDAQ) VS. Omada Health Inc. (NASDAQ) • 15-METRIC TALLY: PNTG 6 — OMDA 2
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: PNTG
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PNTG VS. OMDA) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PNTG OMDA SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 65.70% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE 11.00% -15.70% +26.70 PNTG /roic <GO>
EV/EBITDA & P/E Valuation 23.9x — — TIE /valuation <GO>
Free Cash Flow Yield 2.44% 1.41% +1.03 PNTG /fcf-yield <GO>
Operating Margin 5.50% -4.60% +10.10 PNTG /operating-margins <GO>
Net Profit Margin 3.10% -4.90% +8.00 PNTG /net-margins <GO>
Revenue Growth (YoY) 36.30% 53.20% -16.90 OMDA /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 2.81 8.93 -6.12 OMDA /balance-sheet <GO>
Piotroski F-Score Quality 7/9 7/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 57.6 49.9 +7.70 PNTG /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple 42.2x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.48B $1.20B $280.9M PNTG /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PNTG REV OMDA REV PNTG GROSS % OMDA GROSS % PNTG FCF OMDA FCF
FY 2025 $947.7M $260.2M — 65.7% $36.3M $16.9M
FY 2024 $695.2M $169.8M — 60.6% $30.3M -$34.8M
FY 2023 $544.9M $122.8M — — $33.1M -$49.7M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PNTG // BETA —
OMDA // BETA —